Detail akcie Bioventus Rg-A online

Business Summary: Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
Financial Summary: BRIEF: For the nine months ended 27 September 2025, Bioventus Inc revenues decreased 2% to $410.2M. Net income totaled $8M vs. loss of $35.7M. Revenues reflect U.S. segment decrease of 2% to $362.6M, International segment decrease of 1% to $47.6M. Net Income reflects Impairment of assets decrease from $33.9M (expense) to $0K, Selling, general and administrative exp decrease of 11% to $157.8M (expense).